Exclusive: SEC probe of Valeant began with review of short seller ? sources
 

Exclusive: SEC probe of Valeant began with review of short seller ? sources
NEW YORK (Reuters) - A U.S. regulatory probe of Valeant Pharmaceuticals International Inc , disclosed by the company on Monday, is focused on the drugmaker's relationship with specialty pharmacy Philidor RX Services and was triggered by Valeant’s own request that regulators investigate a short seller's allegations, people familiar with the matter said.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...2c:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...2c:-BTjWOF_DHI
http://feeds.feedburner.com/~r/reute...~4/cKHNC4w7kd0